Recent Updates
Recently added Catalysts
BDX Positive Sentiment Score: 75/100

BD to Present at the 7th Annual Evercore ISI HealthCONx Conference BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the 7th Annual...

Key Takeaway: Becton, Dickinson and Company (BD) announced its participation in the 7th Annual Evercore ISI HealthCONx Conference, scheduled for December 3, 2024. The presentation will be accessible via a live webcast on the company's investor relations website. BD, a major player in global medical technology, focuses on improving medical discovery and care delivery, reflecting its commitment to innovation and health care advancement.

Market Sentiment Analysis

POSITIVE FACTORS

  • BD is participating in a prominent industry conference, highlighting their active role in the medical technology field.
  • The company's commitment to advancing health care through innovation is emphasized, showcasing their strong mission.
  • A live webcast allows for broader access and engagement with investors and stakeholders.

Full Press Release Details

FRANKLIN LAKES, N.J. , Nov. 19, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today announced that it will present at the 7 th Annual Evercore ISI HealthCONx Conference on Tuesday, December 3, 2024 , at 10:50 am Eastern Time .
The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com . A replay of the event will be available on the same webpage following its conclusion.
About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo .
Contacts:
Media : Investors :
Troy Kirkpatrick Adam Reiffe
VP, Public Relations Sr. Director, Investor Relations
858.617.2361 201.847.6927
[email protected] [email protected]
SOURCE BD (Becton, Dickinson and Company)

21 %

Frequently Asked Questions

When will BD present at the Evercore ISI HealthCONx Conference?

BD will present on December 3, 2024, at 10:50 am Eastern Time.

How can I access BD's conference presentation?

The live webcast can be accessed via BD's investor relations website.

Is there a replay available for BD's presentation?

Yes, a replay will be available on BD's investor relations webpage after the event.

What is BD's commitment in healthcare?

BD aims to enhance care delivery and improve medical discovery through innovation.

How many employees does BD have?

BD employs more than 70,000 individuals worldwide.

Last updated: Nov 19, 2024